Multi-triggered self-immolative dendritic compounds
    1.
    发明申请
    Multi-triggered self-immolative dendritic compounds 审中-公开
    多触发自褪色树枝状化合物

    公开(公告)号:US20060269480A1

    公开(公告)日:2006-11-30

    申请号:US11443107

    申请日:2006-05-31

    CPC classification number: A61K31/787 A61K47/555 A61K47/67 A61K47/6899 B82Y5/00

    Abstract: Novel self-immolative dendritic compounds which have a plurality of cleavable trigger units and hence can release a chemical moiety at their focal point upon a multi-triggering mechanism are disclosed. The novel self-immolative dendritic compounds are gated by a molecular logic gate, being either an AND or OR logic gate and hence can be beneficially used in a variety of biological, chemical and physical applications. Processes of preparing, compositions containing and methods utilizing the novel dendritic compounds are further disclosed.

    Abstract translation: 公开了具有多个可裂解触发单元并因此可以在多重触发机制下在其焦点释放化学部分的新型自褪色树枝状化合物。 新型自褪色树枝状化合物由分子逻辑门选通,或者是或逻辑门,因此可以有益地用于各种生物,化学和物理应用。 进一步公开了制备方法,含有组合物和利用新型树枝状化合物的方法。

    Targeted drug-carrying bacteriophages
    4.
    发明授权
    Targeted drug-carrying bacteriophages 失效
    靶向药物携带噬菌体

    公开(公告)号:US07985573B2

    公开(公告)日:2011-07-26

    申请号:US11850942

    申请日:2007-09-06

    CPC classification number: A61K47/62

    Abstract: The present invention relates to the field of drug delivery. More specifically, the invention relates to the preparation and use of a bacteriophage conjugated through a labile/non labile linker or directly to at least 1,000 therapeutic drug molecules such that the drug molecules are conjugated to the outer surface of the bacteriophage. The bacteriophage optionally displays on its coat a ligand that endows it with specificity towards target cells. Thus, there is provided a targeted, high-capacity drug delivery system useful for the treatment of various pathological conditions.

    Abstract translation: 本发明涉及药物递送领域。 更具体地,本发明涉及通过不稳定/非不稳定接头缀合的或直接与至少1,000种治疗性药物分子结合的噬菌体的制备和用途,使得药物分子与噬菌体的外表面缀合。 噬菌体任选地在其外壳上显示赋予其对靶细胞特异性的配体。 因此,提供了可用于治疗各种病理状况的靶向高容量药物递送系统。

    TARGETED DRUG-CARRYING BACTERIOPHAGES
    6.
    发明申请
    TARGETED DRUG-CARRYING BACTERIOPHAGES 审中-公开
    有针对性的药物携带细菌

    公开(公告)号:US20110286971A1

    公开(公告)日:2011-11-24

    申请号:US13159171

    申请日:2011-06-13

    CPC classification number: A61K47/62

    Abstract: The present invention relates to the field of drug delivery. More specifically, the invention relates to the preparation and use of a bacteriophage conjugated through a labile/non labile linker or directly to at least 1,000 therapeutic drug molecules such that the drug molecules are conjugated to the outer surface of the bacteriophage. The bacteriophage optionally displays on its coat a ligand that endows it with specificity towards target cells. Thus, there is provided a targeted, high-capacity drug delivery system useful for the treatment of various pathological conditions.

    Abstract translation: 本发明涉及药物递送领域。 更具体地,本发明涉及通过不稳定/非不稳定接头缀合的或直接与至少1,000种治疗性药物分子结合的噬菌体的制备和用途,使得药物分子与噬菌体的外表面缀合。 噬菌体任选地在其外壳上显示赋予其对靶细胞特异性的配体。 因此,提供了可用于治疗各种病理状况的靶向高容量药物递送系统。

    TARGETED DRUG-CARRYING BACTERIOPHAGES
    8.
    发明申请
    TARGETED DRUG-CARRYING BACTERIOPHAGES 失效
    有针对性的药物携带细菌

    公开(公告)号:US20080057038A1

    公开(公告)日:2008-03-06

    申请号:US11850942

    申请日:2007-09-06

    CPC classification number: A61K47/62

    Abstract: The present invention relates to the field of drug delivery. More specifically, the invention relates to the preparation and use of a bacteriophage conjugated through a labile/non labile linker or directly to at least 1,000 therapeutic drug molecules such that the drug molecules are conjugated to the outer surface of the bacteriophage. The bacteriophage optionally displays on its coat a ligand that endows it with specificity towards target cells. Thus, there is provided a targeted, high-capacity drug delivery system useful for the treatment of various pathological conditions.

    Abstract translation: 本发明涉及药物递送领域。 更具体地,本发明涉及通过不稳定/非不稳定接头缀合的或直接与至少1,000种治疗性药物分子结合的噬菌体的制备和用途,使得药物分子与噬菌体的外表面缀合。 噬菌体任选地在其外壳上显示赋予其对靶细胞特异性的配体。 因此,提供了可用于治疗各种病理状况的靶向高容量药物递送系统。

Patent Agency Ranking